Gilead’s experimental drug for patients with severe Covid-19 infections showed promise in an early analysis

Gilead’s experimental drug for patients with severe Covid-19 infections showed promise in an early analysis https://t.co/ngYsI6lU1v

— Bloomberg (@business) April 11, 2020